| Literature DB >> 33007838 |
Mia Eng Tay1,2, Emma Foster3, Leo Stevenson1,4, Iain Brownlee1,5.
Abstract
There are currently limited data on the dietary habits of young Singaporeans. This study aimed to evaluate the adherence of 17-21 year olds attending different educational institutions using a novel diet-quality scoring method. Dietary data were collected using a single weekday 24 h dietary recall in a cross section of 536 Singaporeans aged 17-21 years. An 11 category scoring system (0.0-100.0) was used to define adherence to food based dietary guidelines. Demographic and self-reported data were also collected via a questionnaire, BMI status, and using Mann-Whitney and Kruskal-Wallis (non-parametric) tests, with post-hoc Bonferroni-corrected tests. The median diet quality score was 48.5 (IQR 40.5, 56.4) for this cohort, with component scores for "Total fruit", "Whole fruit", "Total vegetables", "Dark green leafy & orange vegetables", "Whole grains", "Dairy products", and "Sodium" frequently scoring the minimum value. Median diet quality scores were statistically different for groups by ethnic origin (p < 0.001) and by educational institution (p < 0.001). Intake of fruit, vegetables, and whole grains is minimal, while sodium intake is frequently too high in young Singaporeans. Differences across ethnic groups and types of educational institutions suggest the need for targeted interventions to improve dietary habits in this population.Entities:
Keywords: diet quality; food-based dietary guidelines; fruit and vegetable consumption; salt intake
Mesh:
Year: 2020 PMID: 33007838 PMCID: PMC7601534 DOI: 10.3390/nu12102995
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Scoring elements used to calculate the Healthy Eating Index for Singaporean Adolescents (HEI-SGA).
| No. | Component | Standards for Minimum Score of Zero | Standards for Maximum Score | Maximum Score |
|---|---|---|---|---|
| 1 | Total fruit | No fruit | ≥0.87 serves/1000 kcal | 5 |
| 2 | Whole fruit | No whole fruit | ≥0.43 serves/1000 kcal | 5 |
| 3 | Total vegetables | No vegetables | ≥0.87 serves/1000 kcal | 5 |
| 4 | Dark green leafy & orange vegetables | No dark green leafy and orange vegetables | ≥0.43 serves/1000 kcal | 5 |
| 5 | Whole grains | No whole grains | ≥1.30 serves/1000 kcal | 10 |
| 6 | Dairy and alternatives | No dairy and alternatives | ≥0.43 serves/1000 kcal | 10 |
| 7 | Total protein foods | No protein food | ≥1.08 serves/1000 kcal | 10 |
| 8 | Total rice & alternatives | No rice and alternatives | ≥3.04 serves/1000 kcal | 10 |
| 9 | Total fat | ≥40% of energy | ≤30% of energy | 10 |
| 10 | Saturated fat | ≥20% of energy | ≤10% of energy | 10 |
| 11 | Sodium | ≥870 mg/1000 kcal | ≤435 mg/1000 kcal | 10 |
| - | TOTAL | - | - | 90 |
Median component and total HEI-SGA values across all participants and by sex.
| All ( | Female ( | Male ( | ||
|---|---|---|---|---|
| Components | Median (IQR) | Median (IQR) | Median (IQR) | * |
| Total fruit | 0.0 (0.0, 4.1) | 0.0 (0.0, 4.8) | 0.0 (0.0, 3.2) | 0.001 |
| Whole fruit | 0.0 (0.0, 5.0) | 0.0 (0.0, 5.0) | 0.0 (0.0, 0.0) | <0.001 |
| Total vegetables | 0.6 (0.0, 2.4) | 0.9 (0.0, 2.7) | 0.3 (0.0, 1.7) | 0.014 |
| DGLOV | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.009 |
| Total rice & alternatives | 10.0 (7.9, 10.0) | 10.0 (7.4, 10.0) | 10.0 (8.5, 10.0) | 0.013 |
| Whole grains | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.956 |
| Dairy and alternatives | 1.9 (0.0, 7.0) | 1.9 (0.0, 7.5) | 2.1 (0.0, 6.4) | 0.811 |
| Total protein foods | 10 (6.9, 10.0) | 10.0 (5.7, 10.0) | 10.0 (9.2, 10.0) | <0.001 |
| Total Fat | 10 (8.4, 10.0) | 10.0 (8.0, 10.0) | 10.0 (8.8, 10.0) | 0.621 |
| Saturated fat | 10.0 (7.1, 10.0) | 9.8 (6.9, 10.0) | 10.0 (7.4, 10.0) | 0.097 |
| Sodium | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.722 |
| Total HEI-SGA score | 48.5 (40.5, 56.4) | 48.2 (40.1, 56.4) | 48.8 (42.1, 56.4) | 0.883 |
* Based on independent sample Mann-Whitney U Tests between males and females. DGLOV—dark green leafy and orange vegetables, HEI-SGA—Healthy Eating Index for Singaporean adolescents, IQR—diet quality score.
Median component and total HEI-SGA values across all participants and by BMI category.
| Median (IQR) Component or Total Score | |||||
|---|---|---|---|---|---|
| At Risk of Nutrient Deficiency ( | Healthy ( | Moderate Risk ( | High Risk ( | * | |
| Total fruit | 0.0 (0.0, 3.5) | 0.0 (0.0, 4.2) | 0.0 (0.0, 4.8) | 0.0 (0.0, 4.1) | 0.757 |
| Whole fruit | 0.0 (0.0, 3.9) | 0.0 (0.0, 5.0) | 0.0 (0.0, 3.8) | 0.0 (0.0, 5.0) | 0.349 |
| Total vegetables | 0.0 (0.0, 1.5) | 0.5 (0.0, 2.5) | 0.6 (0.0, 2.6) | 1.3 (0.0, 2.4) | 0.328 |
| DGLOV | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.402 |
| Total rice & alternatives | 10.0 (7.7, 10.0) b | 10.0 (8.3, 10.0) b | 10.0 (8.0, 10.0) b | 8.5 (7.2, 10.0) a | 0.007 |
| Whole grains | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.581 |
| Dairy | 2.6 (0.0, 5.4) b | 2.1 (0.0, 7.0) b | 2.9 (0.0, 9.4) b | 0.0 (0.0, 2.9) a | 0.008 |
| Total protein foods | 10.0 (7.8, 10.0) | 10.0 (6.9, 10.0) | 10.0 (5.8, 10.0) | 10.0 (6.2, 10.0) | 0.766 |
| Total Fat | 10.0 (8.6, 10.0) | 10.0 (7.2, 10.0) | 10.0 (9.8, 10.0) | 10.0 (8.4, 10.0) | 0.372 |
| Saturated fat | 9.7 (7.3, 10.0) | 9.7 (7.0, 10.0) | 10.0 (7.7, 10.0) | 10.0 (7.0, 10.0) | 0.476 |
| Sodium | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.462 |
| Total HEI-SGA score | 47.5 (41.7, 55.2) | 48.8 (40.1, 56.1) | 49.1 (41.9, 59.7) | 47.0 (40.1, 52.6) | 0.470 |
* Based on independent samples, Kruskal-Wallis. Groups that do not share a superscript are significantly different from each other by post-hoc Bonferroni tests. DGLOV—dark green leafy and orange vegetables. BMI categories used in Singapore for this age group: “At risk of nutrient deficiency” < 18.5; “Heathy range” 18.5–22.9; “Moderate risk (of developing cardiovascular diseases) 23.0–27.0; “High risk” > 27.0 [17].
Median component and total HEI-SGA values across all participants by ethnicity.
| Median (IQR) Component and Total Scores | ||||
|---|---|---|---|---|
| Chinese ( | Indian ( | Malay ( | ||
| Total fruit | 0.0 (0.0, 5.0) a | 0.0 (0.0, 3.5) b | 0.0 (0.0, 1.0) b | <0.001 |
| Whole fruit | 0.0 (0.0, 5.0) a | 0.0 (0.0, 3.2) b | 0.0 (0.0, 0.0) b | <0.001 |
| Total vegetables | 1.4 (0.0, 3.6) a | 0.3 (0.0, 1.5) b | 0.0 (0.0, 0.9) b | <0.001 |
| DGLOV | 0.0 (0.0, 3.7) a | 0.0 (0.0, 0.0) b | 0.0 (0.0, 0.0) b | <0.001 |
| Total rice & alternatives | 10.0 (8.0, 10.0) | 10.0 (7.9, 10.0) | 10.0 (7.4, 10.0) | 0.458 |
| Whole grains | 0.0 (0.0, 0.0) a | 0.0 (0.0, 0.0) a,b | 0.0 (0.0, 0.0) b | 0.001 |
| Dairy | 2.2 (0.0, 7.0) a,b | 2.8 (0.0, 7.8) a | 0.0 (0.0, 5.3) b | 0.013 |
| Total protein foods | 10.0 (6.9, 10.0) | 10.0 (6.6, 10.0) | 10.0 (7.1, 10.0) | 0.705 |
| Total Fat | 10.0 (9.7, 10.0) a | 10.0 (6.7, 10.0) b | 10.0 (6.0, 10.0) b | 0.001 |
| Saturated fat | 10.0 (8.1, 10.0) a | 9.5 (5.8, 10.0) b | 9.1 (6.4, 10.0) b | <0.001 |
| Sodium | 0.0 (0.0, 0.0) b | 0.0 (0.0, 0.0) a | 0.0 (0.0, 0.0) a | 0.009 |
| Total HEI-SGA score | 52.4 (44.4, 60.4) a | 47.6 (38.5, 54.9) b | 44.4 (37.2, 50.2) c | <0.001 |
* Based on independent samples, Kruskal-Wallis. Groups that do not share a superscript are significantly different from each other by post-hoc Bonferroni tests. DGLOV—dark green leafy and orange vegetables.
Median component and total HEI-SGA values in Singaporean students attending different educational institutions.
| Median (IQR) Component and Total Scores | ||||
|---|---|---|---|---|
| Components | ITE ( | JC ( | POLY ( | |
| Total fruit | 0.0 (0.0, 3.2) b | 4.6 (0.0, 5.0) a | 0.0 (0.0, 3.2) b | <0.001 |
| Whole fruit | 0.0 (0.0, 0.4) b | 4.2 (0.0, 5.0) a | 0.0 (0.0, 4.0) b | <0.001 |
| Total vegetables | 0.7 (0.0, 2.6) b | 2.7 (0.0, 5.0) a | 0.0 (0.0, 1.5) b | <0.001 |
| DGLOV | 0.0 (0.0, 0.0) b | 0.0 (0.0, 3.7) a | 0.0 (0.0, 0.0) b | <0.001 |
| Total rice & alternatives | 10.0 (6.3, 10.0) b | 10.0 (8.8, 10.0) a | 10.0 (7.9, 10.0) a,b | 0.015 |
| Whole grains | 0.0 (0.0, 0.0) a | 0.0 (0.0, 0.0) b | 0.0 (0.0, 0.0) b | 0.004 |
| Dairy | 0.0 (0.0, 4.0) b | 3.4 (0.0, 8.4) a | 2.1 (0.0, 7.3) a,b | 0.002 |
| Total protein foods | 10.0 (6.7, 10.0) | 10.0 (7.6, 10.0) | 10.0 (6.4, 10.0) | 0.433 |
| Total Fat | 10.0 (9.8, 10.0) | 10.0 (9.4, 10.0) | 10.0 (7.0, 10.0) | 0.034 |
| Saturated fat | 10.0 (8.6, 10.0) b | 10.0 (7.7, 10.0) a,b | 9.7 (6.5, 10.0) a | 0.008 |
| Sodium | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.788 |
| Total HEI-SGA score | 47.4 (40.2, 52.6) b | 56.6 (48.1, 64.4) a | 47.4 (38.2, 54.7) b | <0.001 |
* Based on independent samples, Kruskal-Wallis. Groups that do not share a superscript are significantly different from each other by post-hoc Bonferroni-corrected tests. ITE—Institute of Technical Education, JC—Junior College, POLY—polytechnic, DGLOV–dark green leafy and orange vegetable.
Strengthening the reporting of observation studies in epidemiology (STROBE) checklist of recommended items that should be included in reports of cross-sectional studies.
| Section | Item | Recommendation | Reported in |
|---|---|---|---|
| Title and abstract | 1 | (a) Indicate the study’s design with a commonly used term in the title or the abstract | Title and Abstract (p. 1 lines 19–20) |
| (b) Provide in the abstract an informative and balanced summary of what was done and what was found | Abstract (p. 1) | ||
| Introduction | |||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | Introduction (p. 1–2) |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses | Objectives p. 1, lines 71–73. No prespecified hypotheses included. |
| Methods | |||
| Study design | 4 | Present key elements of the study design early in the paper | Abstract, Introduction, and Methods |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | Exposure and follow-up not relevant to study design. Recruitment data collection dates included (Methods, p. 3, line 97). |
| Participants | 6 | (a) Give the eligibility criteria and the sources and methods of selection of participants | Methods, p. 3, lines 81–83) |
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | Outcomes defined throughout Methods section. Unmeasured potential confounders discussed (Discussion, line 256–262 and lines 269–272). Exposures and diagnostic criteria not applicable to current study. |
| Data sources/measurement | 8 | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | Presented throughout the Methods section |
| Bias | 9 | Describe any efforts to address potential sources of bias | Methods, particularly lines 85–96 |
| Study size | 10 | Explain how the study size was arrived at | Only an estimate of the adequacy of total population was considered, with broader convenience sampling based on available study timeline (Methods, lines 97–101) |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | Data handling described in Methods (lines 86–128) |
| Statistical methods | 12 | (a) Describe all statistical methods, including those used to control for confounding variables | Methods (lines 129–134) |
| (b) Describe any methods used to examine subgroups and interactions | Methods and Results | ||
| (c) Explain how missing data were addressed | Not applicable (see Results line 136) | ||
| (d) If applicable, describe analytical methods taking account of sampling strategy | Not carried out | ||
| (e) Describe any sensitivity analyses | Not carried out. Potential unmeasured confounders discussed | ||
| Results | |||
| Participants | 13 | (a) Report numbers of individuals at each stage of study—e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | No data collected on potential eligibility or number of individuals who declined to take part. |
| (b) Give reasons for non-participation at each stage | Not applicable (see 13 (a)). | ||
| (c) Consider use of a flow diagram | Not applicable (see 13 (a)) | ||
| Descriptive data | 14 | (a) Give characteristics of the study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders | Results |
| (b) Indicate the number of participants with missing data for each variable of interest | Not applicable (see 13 (a)) | ||
| Outcome data | 15 | Report numbers of outcome events or summary measures | Results |
| Main results | 16 | (a) Give unadjusted estimates and if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence interval). Make clear which confounders were adjusted for and why they were included | Confounder-adjusted estimates not applicable to the current study design |
| (b) Report category boundaries when continuous variables were categorized | BMI categories used noted in Results ( | ||
| (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | Not applicable | ||
| Other analyses | 17 | Report other analyses done—e.g., analyses of subgroups and interactions and sensitivity analyses | Analyses of sub-groups described throughout Results. Interaction and sensitivity analyses not carried out. |
| Discussion | |||
| Key results | 18 | Summarise key results with reference to study objectives | Discussion (lines 191–257) |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both the direction and magnitude of any potential bias | Discussion (lines 241–250, lines 258–264, lines 269–274, lines 275–301) |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | Major interpretations of results presented in lines 317–318 of Conclusions. |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results | Considered in relation to broader limitations of the study design (lines 275–301). Conclusions related to this are presented on lines 318–322 |
| Other information | |||
| Funding | 22 | Give the source of funding and the role of the funders for the present study and if applicable, for the original study on which the present article is based | Presented post-Conclusions (lines 329–330) |